The approval from Health Canada marked a significant milestone in their GLP-1 journey, showcasing their expertise in complex product development, peptide science, and the ability to meet stringent global regulatory standards
Neither body of evidence is sufficient to support clinical recommendations
Sarcopenia Approximately 40% of the weight reduction associated with GLP-1 RAs is derived from a lean body mass, which raises significant concerns regarding its potential negative impact on skeletal muscle functionality [110]
The official FDA prescribing information for tirzepatide says to start at 2.5 mg regardless of what GLP-1 drug you were on before
However, these are relatively easy to avoid and if youre reading this blog chances are youre already making positive health choices
GLP-1s offer a glimpse into what medicine can donot just to help you look better, but feel better too